ATE304548T1 - Antibakterielle verbindungen - Google Patents

Antibakterielle verbindungen

Info

Publication number
ATE304548T1
ATE304548T1 AT03004404T AT03004404T ATE304548T1 AT E304548 T1 ATE304548 T1 AT E304548T1 AT 03004404 T AT03004404 T AT 03004404T AT 03004404 T AT03004404 T AT 03004404T AT E304548 T1 ATE304548 T1 AT E304548T1
Authority
AT
Austria
Prior art keywords
compounds
antibacterial compounds
xvi
xiv
xiii
Prior art date
Application number
AT03004404T
Other languages
English (en)
Inventor
Inukai Masatoshi
Kaneko Masakatsu
Takatsu Toshio
Hotoda Hitoshi
Arai Masatoshi
Miyakoshi Shunichi
Kizuka Masaaki
Ogawa Yasumasa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE304548T1 publication Critical patent/ATE304548T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/167Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/40Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT03004404T 1998-07-09 1999-07-09 Antibakterielle verbindungen ATE304548T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19428598 1998-07-09
JP26944598 1998-09-24

Publications (1)

Publication Number Publication Date
ATE304548T1 true ATE304548T1 (de) 2005-09-15

Family

ID=26508414

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99929772T ATE356825T1 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen
AT03004404T ATE304548T1 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99929772T ATE356825T1 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen

Country Status (23)

Country Link
US (2) US6472384B1 (de)
EP (3) EP1319666B1 (de)
KR (2) KR100622889B1 (de)
CN (1) CN1181087C (de)
AT (2) ATE356825T1 (de)
AU (1) AU751470B2 (de)
BR (1) BR9911965A (de)
CA (1) CA2337225C (de)
DE (2) DE69927306T2 (de)
DK (2) DK1319666T3 (de)
ES (2) ES2284260T3 (de)
HK (2) HK1053063A1 (de)
HU (1) HUP0103711A3 (de)
ID (1) ID27955A (de)
IL (3) IL140731A0 (de)
NO (1) NO322083B1 (de)
NZ (1) NZ509233A (de)
PL (1) PL200426B1 (de)
PT (1) PT1095947E (de)
RU (1) RU2209210C2 (de)
TR (1) TR200100059T2 (de)
WO (1) WO2000002892A1 (de)
ZA (1) ZA200100200B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
WO2002024491A1 (de) 2000-09-25 2002-03-28 Volkswagen Ag Airbagvorrichtung und betriebsverfahren dafür
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
EP1670314A4 (de) * 2003-09-05 2009-02-25 Sequella Inc Verfahren und zusammensetzungen enthaltend diamine als neue therapeutika für tuberkulose
EP1771435A4 (de) * 2004-06-19 2008-02-13 Human Biomolecular Res Inst Modulatoren von neurotransmittern des zentralen nervensystems
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
WO2009136965A1 (en) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions and methods comprising capuramycin analogues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives

Also Published As

Publication number Publication date
PL200426B1 (pl) 2009-01-30
EP1319406A1 (de) 2003-06-18
HK1053127B (en) 2005-12-30
TR200100059T2 (tr) 2001-05-21
HUP0103711A2 (hu) 2002-02-28
CA2337225C (en) 2009-05-26
DE69927306D1 (de) 2005-10-20
NO20010105L (no) 2001-03-08
HUP0103711A3 (en) 2003-11-28
KR100622889B1 (ko) 2006-09-12
CA2337225A1 (en) 2000-01-20
DE69927306T2 (de) 2006-07-06
RU2209210C2 (ru) 2003-07-27
ID27955A (id) 2001-05-03
AU751470B2 (en) 2002-08-15
EP1095947B1 (de) 2007-03-14
DE69935513T2 (de) 2007-11-29
PT1095947E (pt) 2007-06-20
KR20010083101A (ko) 2001-08-31
AU4650599A (en) 2000-02-01
US20030069204A1 (en) 2003-04-10
NZ509233A (en) 2003-05-30
HK1053127A1 (en) 2003-10-10
IL187551A0 (en) 2008-03-20
PL345403A1 (en) 2001-12-17
IL140731A (en) 2008-06-05
NO20010105D0 (no) 2001-01-08
WO2000002892A1 (fr) 2000-01-20
ZA200100200B (en) 2002-06-26
ES2248654T3 (es) 2006-03-16
HK1053063A1 (en) 2003-10-10
ATE356825T1 (de) 2007-04-15
KR20060011919A (ko) 2006-02-03
IL140731A0 (en) 2002-02-10
EP1319666B1 (de) 2005-09-14
KR100729196B1 (ko) 2007-06-19
IL187551A (en) 2009-12-24
DE69935513D1 (de) 2007-04-26
EP1095947A1 (de) 2001-05-02
DK1319666T3 (da) 2005-12-05
US6844173B2 (en) 2005-01-18
US6472384B1 (en) 2002-10-29
DK1095947T3 (da) 2007-07-16
ES2284260T3 (es) 2007-11-01
NO322083B1 (no) 2006-08-14
CN1317008A (zh) 2001-10-10
EP1319666A1 (de) 2003-06-18
EP1095947A4 (de) 2002-01-16
BR9911965A (pt) 2001-05-29
CN1181087C (zh) 2004-12-22

Similar Documents

Publication Publication Date Title
IL187551A0 (en) Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
EG25017A (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
ECSP003699A (es) Inhibidores de fab i
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
NO951198D0 (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ZA9710796B (en) Oxyiminopregnanecarbolactones.
GEP20094834B (en) Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections
WO2001074788A8 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
MX9708611A (es) Compuestos de dialquiltiacumicina.
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
EP0708770A1 (de) Amid-derivate von 16-gliedrige heterocyclen als antibiotische macrolide
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
CY1112050T1 (el) Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
AU5390900A (en) Potassium channel blocking agents
WO2000010998A3 (en) Pyridone antibiotic with improved safety profile
TR199701298T1 (xx) Tetralinler.
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
ES8102590A1 (es) Metodo de producir antibioticos del tipo basado en streptomyces.
FR2412564A1 (fr) Nouvelles 2' -n-acyl- et alkyl-6' -n-alkyl- et 6', 6' -di-n-alkyl-fortimicines a et b, utiles notamment comme antibiotiques

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1319666

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee